Obesity
Not yet recruitingKAI-9531 in Adults With Obesity or Overweight and Diabetes
KAI-9531 in Adults With Obesity or Overweight and Diabetes
Bulgaria- Participants:18–64 years · 65+ years
- Substances:HRS 9531
Rare diseases
Investigational molecules
Locations
KAI-9531 in Adults With Obesity or Overweight and Diabetes
BulgariaA study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.
BulgariaA study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
BulgariaTesting GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety
BulgariaStudy of telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus
BulgariaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
BulgariaStudy on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older
BulgariaStudy on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis
BulgariaStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
BulgariaSafety and Efficacy of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis: A Long‑Term Randomized Placebo‑Controlled Study
BulgariaStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
BulgariaEfficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.